| |
| |
|
| Insider
Information: |
Opaleye Management Inc. |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
11,359,363 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$66,817,571 |
|
|
| Total
Shares |
11,359,363 |
|
|
| Total
Value |
$66,817,571 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
123
|
5
|
|
Stock
price went up :
|
64
|
3
|
| Stock
price went down : |
59
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
1.1
|
1.5
|
| Percentage
Gain/Loss : |
 14.2%
|
 -54.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harrow Health Inc |
HROW |
10% Owner |
2015-05-19 |
0 |
2024-04-25 |
3,815,000 |
Premium* |
|
|
Ocular Therapeutix, Inc |
OCUL |
10% Owner |
|
0 |
2020-01-02 |
4,918,500 |
Premium* |
|
|
Eton Pharmaceuticals, Inc. |
ETON |
10% Owner |
|
0 |
2021-11-17 |
2,375,000 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2020-08-27 |
0 |
2023-11-10 |
0 |
Premium* |
|
|
Protara Therapeutics, Inc |
TARA |
10% Owner |
2020-09-24 |
0 |
2024-05-17 |
126,050 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2022-06-10 |
0 |
2022-11-03 |
124,813 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-09-15 |
4 |
B |
$3.80 |
$27,740 |
I/I |
7,300 |
132,300 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-09-15 |
4 |
B |
$8.10 |
$33,680 |
I/I |
4,158 |
120,875 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-09-16 |
4 |
B |
$8.08 |
$19,173 |
I/I |
2,372 |
121,247 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-09-19 |
4 |
B |
$8.09 |
$145,584 |
I/I |
18,000 |
122,247 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-09-19 |
4 |
B |
$1.87 |
$9,367 |
I/I |
5,000 |
375,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-09-20 |
4 |
B |
$1.85 |
$18,524 |
I/I |
10,000 |
385,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-09-22 |
4 |
B |
$1.73 |
$29,943 |
I/I |
17,311 |
398,900 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-09-23 |
4 |
B |
$7.99 |
$54,393 |
I/I |
6,804 |
122,551 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-09-27 |
4 |
B |
$1.69 |
$2,877 |
I/I |
1,700 |
400,600 |
1.42 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-09-28 |
4 |
B |
$9.77 |
$108,354 |
I/I |
11,085 |
158,817 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-09-29 |
4 |
B |
$1.74 |
$16,370 |
I/I |
9,400 |
410,000 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-10-11 |
4 |
B |
$8.00 |
$128,000 |
I/I |
16,000 |
123,551 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-10-18 |
4 |
B |
$1.65 |
$20,625 |
I/I |
12,500 |
4,125,000 |
1.5 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2022-11-03 |
4 |
B |
$7.81 |
$158,285 |
I/I |
20,262 |
124,813 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-12-06 |
4 |
S |
$1.44 |
$2,216 |
I/I |
(1,539) |
4,010,000 |
0 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-12-06 |
4 |
OE |
$0.01 |
$2,215 |
I/I |
221,539 |
4,011,539 |
0 |
- |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2022-12-14 |
4 |
B |
$10.52 |
$4,536,045 |
I/I |
431,183 |
175,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2022-12-14 |
4 |
B |
$1.24 |
$209,877 |
I/I |
167,500 |
440,000 |
1.5 |
% |
|
| TARA |
Protara Therapeutics, Inc |
10% Owner |
– – • |
2022-12-30 |
4 |
S |
$2.71 |
$41,949 |
I/I |
(15,473) |
130,000 |
0 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2023-03-09 |
4 |
B |
$1.38 |
$240,821 |
I/I |
174,508 |
4,324,508 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-19 |
4 |
B |
$14.65 |
$205,366 |
I/I |
14,017 |
3,614,017 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-09-20 |
4 |
B |
$14.49 |
$86,710 |
I/I |
5,983 |
3,620,000 |
1.5 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
10% Owner |
– – • |
2023-11-10 |
4 |
S |
$0.29 |
$1,401,571 |
I/I |
(4,764,008) |
0 |
0 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2023-11-15 |
4 |
B |
$8.03 |
$200,735 |
I/I |
25,000 |
3,645,000 |
1.5 |
% |
|
| HROW |
Harrow Health Inc |
10% Owner |
– – • |
2024-03-20 |
4 |
B |
$9.65 |
$488,290 |
I/I |
50,600 |
3,695,600 |
1.5 |
% |
|
158 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
